NEWELL WILLIAM J 4
4 · SUTRO BIOPHARMA, INC. · Filed Mar 6, 2024
Insider Transaction Report
Form 4
NEWELL WILLIAM J
DirectorCEO
Transactions
- Exercise/Conversion
Common Stock
2024-03-04+31,125→ 219,248 total - Tax Payment
Common Stock
2024-03-04$4.79/sh−11,105$53,193→ 208,143 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2024-03-04−31,125→ 62,250 totalExp: 2026-03-04→ Common Stock (31,125 underlying)
Holdings
- 116,525(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
- [F2]The securities are held of record by the reporting person as trustee of the William J. Newell Family Trust DTD 03/15/2019.
- [F3]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F4]The RSUs vest as to 1/4th of the total award annually beginning on March 4, 2023, subject to continued service through each vesting date.